KURA
Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.73
+0.09%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 7.09x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.55x
- Price / sales
- 13.51x
- Price / cash flow
- -9.34x
Enterprise value
- Enterprise value
- $548.9M
- EV / sales
- 7.11x
- EV / EBITDA
- -1.88x
- EV / EBIT
- -1.73x
- Market cap
- $1.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026